Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Adenosine A1 agonists for the treatment of glaucoma and ocular hypertension

Adenosine A1 agonists for the treatment of glaucoma and ocular hypertension

US Patent 9040566 · Granted May 26, 2015

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted hydantoinamides as ADAMTS7 antagonists2025
Substituted pyrazolo piperidine carboxylic acids2025
Antibody drug conjugates with enzymatically cleavable groups2024
Substituted 5-fluoro-1H-pyrazolopyridines and their use2024
Prodrugs of cytotoxic active agents having enzymatically cleavable groups2024
Site specific homogeneous with KSP inhibitors2023
Combination containing sGC stimulators and mineralocorticoid receptor antagonist2023
Prodrugs of cytotoxic active agents having enzymatically cleavable groups2023
Antibody drug conjugates (ADCs) having enzymatically cleavable groups2023
Specific antibody-drug-conjugates (ADCs) with KSP inhibitors and anti-CD123-anti2023
Method of identifying a subgroup of patients suffering from dcSSc which benefits2022
Antibody drug conjugates (ADCS) having enzymatically cleavable groups2022